GB9115107D0 - Pharmaceutical agents - Google Patents

Pharmaceutical agents

Info

Publication number
GB9115107D0
GB9115107D0 GB919115107A GB9115107A GB9115107D0 GB 9115107 D0 GB9115107 D0 GB 9115107D0 GB 919115107 A GB919115107 A GB 919115107A GB 9115107 A GB9115107 A GB 9115107A GB 9115107 D0 GB9115107 D0 GB 9115107D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical agents
pharmaceutical
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919115107A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB919115107A priority Critical patent/GB9115107D0/en
Publication of GB9115107D0 publication Critical patent/GB9115107D0/en
Priority to IL10009191A priority patent/IL100091A/en
Priority to CA002319308A priority patent/CA2319308C/en
Priority to CA002056066A priority patent/CA2056066C/en
Priority to HU913865A priority patent/HU213211B/en
Priority to MX9102473A priority patent/MX9102473A/en
Priority to TW080109698A priority patent/TW276181B/zh
Priority to ES91311504T priority patent/ES2079589T3/en
Priority to DK91311504.4T priority patent/DK0490648T3/en
Priority to NZ240939A priority patent/NZ240939A/en
Priority to SU5010340/14A priority patent/RU2106140C1/en
Priority to UA5010340A priority patent/UA27711C2/en
Priority to PH43619A priority patent/PH30928A/en
Priority to MYPI91002302A priority patent/MY106315A/en
Priority to US07/805,421 priority patent/US5319097A/en
Priority to SK3756-91A priority patent/SK279813B6/en
Priority to APAP/P/1991/000340A priority patent/AP285A/en
Priority to AU88994/91A priority patent/AU656157B2/en
Priority to KR1019910022917A priority patent/KR0183027B1/en
Priority to BE9101127A priority patent/BE1004229A5/en
Priority to JP3327783A priority patent/JP2585495B2/en
Priority to FR9115366A priority patent/FR2670488B1/en
Priority to FI915826A priority patent/FI101193B1/en
Priority to GB9126354A priority patent/GB2251791B/en
Priority to ITMI913324A priority patent/IT1256282B/en
Priority to CN91111566A priority patent/CN1043405C/en
Priority to AT91311504T priority patent/ATE131048T1/en
Priority to EP91311504A priority patent/EP0490648B1/en
Priority to GB9418154A priority patent/GB2280606B/en
Priority to CS913756A priority patent/CZ283181B6/en
Priority to DE69115229T priority patent/DE69115229T2/en
Priority to DE4140858A priority patent/DE4140858A1/en
Priority to IE431091A priority patent/IE75348B1/en
Priority to US08/116,781 priority patent/US5482963A/en
Priority to US08/403,132 priority patent/US5504216A/en
Priority to US08/474,191 priority patent/US5612367A/en
Priority to HU95P/P00181P priority patent/HU211126A9/en
Priority to GR950403190T priority patent/GR3018318T3/en
Priority to KR1019960036692A priority patent/KR100207802B1/en
Priority to FI972528A priority patent/FI106021B/en
Priority to HK81397A priority patent/HK81397A/en
Priority to HK81597A priority patent/HK81597A/en
Priority to FI980376A priority patent/FI980376A0/en
Priority to SK664-98A priority patent/SK279814B6/en
Priority to US09/114,225 priority patent/US5993859A/en
Priority to CN98121369A priority patent/CN1105705C/en
Priority to US09/447,414 priority patent/US6143775A/en
Pending legal-status Critical Current

Links

GB919115107A 1990-12-12 1991-07-12 Pharmaceutical agents Pending GB9115107D0 (en)

Priority Applications (47)

Application Number Priority Date Filing Date Title
GB919115107A GB9115107D0 (en) 1991-07-12 1991-07-12 Pharmaceutical agents
IL10009191A IL100091A (en) 1990-12-12 1991-11-19 Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
CA002319308A CA2319308C (en) 1990-12-12 1991-11-22 Pharmaceutical agents
CA002056066A CA2056066C (en) 1990-12-12 1991-11-22 A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it
HU913865A HU213211B (en) 1990-12-12 1991-12-09 Process for producing new physical modification of n-/4-(5-(cyclopentyl oxycarbonyl)amino-1-methylindol-3-yl-methyl)-3-methoxybenzoyl/-2-methyl benzenesulphonamide and pharmaceutical compositions comprising the same
MX9102473A MX9102473A (en) 1990-12-12 1991-12-10 PHARMACEUTICAL AGENTS.
TW080109698A TW276181B (en) 1990-12-12 1991-12-10
ES91311504T ES2079589T3 (en) 1990-12-12 1991-12-11 PHARMACEUTICAL AGENTS.
DK91311504.4T DK0490648T3 (en) 1990-12-12 1991-12-11 Pharmaceuticals
NZ240939A NZ240939A (en) 1990-12-12 1991-12-11 A physical form of n-[4-[5-(cyclopentyloxycarbonyl)-amino-1-methylindol-3-yl- methyl]-3-methoxybenzoyl]-2-methyl-benzenesulphonamide with particular ir spectrum
SU5010340/14A RU2106140C1 (en) 1990-12-12 1991-12-11 Pharmaceutical composition, method for its obtaining, physical form of n-;4-;5-(cyclopentyloxycarbonyl)amino-1-methilindol-3-il-methyl-3- -methoxybenzoil
UA5010340A UA27711C2 (en) 1991-07-12 1991-12-11 Pharmaceutical composition useful in the treatment of diseases in which leukotrienes are implicated
PH43619A PH30928A (en) 1990-12-12 1991-12-11 Pharmaceutical agents.
MYPI91002302A MY106315A (en) 1990-12-12 1991-12-11 Pharmaceutical agents
US07/805,421 US5319097A (en) 1990-12-12 1991-12-11 Pharmaceutical agents
SK3756-91A SK279813B6 (en) 1990-12-12 1991-12-11 Pharmaceutical composition, process for preparation thereof, and intermediate usable therein
APAP/P/1991/000340A AP285A (en) 1990-12-12 1991-12-11 Pharmaceutical composition comprising a particular pysical form of a heterocyclic amide derivative.
AU88994/91A AU656157B2 (en) 1990-12-12 1991-12-11 Pharmaceutical agents
KR1019910022917A KR0183027B1 (en) 1990-12-12 1991-12-11 Pharmaceutical agents
BE9101127A BE1004229A5 (en) 1990-12-12 1991-12-11 PHARMACEUTICAL AGENTS.
JP3327783A JP2585495B2 (en) 1990-12-12 1991-12-11 Medicine
FR9115366A FR2670488B1 (en) 1990-12-12 1991-12-11 PHARMACEUTICAL COMPOSITION CONTAINING A PARTICULAR PHYSICAL FORM OF A HETEROCYCLIC AMIDE AND METHOD FOR PREPARING THE SAME.
FI915826A FI101193B1 (en) 1990-12-12 1991-12-11 A process for the preparation of a pharmaceutical composition comprising a physical form of N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl] -3-methoxybenzoyl] -2-methylbenzenesulfonamide
GB9126354A GB2251791B (en) 1990-12-12 1991-12-11 Pharmaceutical compositions containing benzenesulphonamides
ITMI913324A IT1256282B (en) 1990-12-12 1991-12-11 PHARMACEUTICAL COMPOSITION THAT INCLUDES A PARTICULAR PHYSICAL FORM OF A DERIVATIVE OF A HETEROCYCLIC STARCH
CN91111566A CN1043405C (en) 1990-12-12 1991-12-11 Pharmaceutical agents
AT91311504T ATE131048T1 (en) 1990-12-12 1991-12-11 DRUG.
EP91311504A EP0490648B1 (en) 1990-12-12 1991-12-11 Pharmaceutical agents
GB9418154A GB2280606B (en) 1990-12-12 1991-12-11 Physical forms of benzenesulphonamides
CS913756A CZ283181B6 (en) 1990-12-12 1991-12-11 Pharmaceutical preparation, process of its preparation, process for preparing active component thereof and intermediate for such process
DE69115229T DE69115229T2 (en) 1990-12-12 1991-12-11 Drug.
DE4140858A DE4140858A1 (en) 1990-12-12 1991-12-11 PHARMACEUTICAL AGENTS
IE431091A IE75348B1 (en) 1990-12-12 1991-12-11 Pharmaceutical agents
US08/116,781 US5482963A (en) 1990-12-12 1993-09-03 Pharmaceutical agents useful as leukotriene antagonists
US08/403,132 US5504216A (en) 1990-12-12 1995-03-13 Method for reparing an amorphous sulfonamide
US08/474,191 US5612367A (en) 1990-12-12 1995-06-07 Method of enhancing bioavailability of pharmaceutical agents
HU95P/P00181P HU211126A9 (en) 1990-12-12 1995-06-09 Pharmaceutical agents
GR950403190T GR3018318T3 (en) 1990-12-12 1995-12-07 Pharmaceutical agents.
KR1019960036692A KR100207802B1 (en) 1990-12-12 1996-08-30 N- [4(5-cyclopentyloxycarbonyl) amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methylbenzenesulfoneamide and the process for the preparation thereof
FI972528A FI106021B (en) 1990-12-12 1997-06-13 Process for preparing a physical form of N-[4-[5- (cyclopentyloxycarbonyl)amino-1-methylindol-3-ylmethyl]-3- methoxybenzoyl]-2-methylbenzenesulphonamide
HK81397A HK81397A (en) 1990-12-12 1997-06-19 Pharmaceutical compositions containing benzene-sulphonamides
HK81597A HK81597A (en) 1990-12-12 1997-06-19 Physical forms of benzene-sulphonamides
FI980376A FI980376A0 (en) 1990-12-12 1998-02-18 Pharmaceutical composition containing a physical form of N- / 4- / 5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl / -3-methoxybenzoyl / -2-methylbenzenesulfonamide
SK664-98A SK279814B6 (en) 1990-12-12 1998-05-20 Method for the preparation of a n-[4-[5-(cyclopentyloxycarbonyl)- -amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- -benzenesulphonamide, and intermediate usable for said method
US09/114,225 US5993859A (en) 1990-12-12 1998-07-13 Pharmaceutical agents
CN98121369A CN1105705C (en) 1990-12-12 1998-10-14 Preparation of heterocyclic amide derivative with specific physical status
US09/447,414 US6143775A (en) 1990-12-12 1999-11-23 Process for preparing pharmaceutical composition containing a heterocyclic amide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919115107A GB9115107D0 (en) 1991-07-12 1991-07-12 Pharmaceutical agents

Publications (1)

Publication Number Publication Date
GB9115107D0 true GB9115107D0 (en) 1991-08-28

Family

ID=10698278

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919115107A Pending GB9115107D0 (en) 1990-12-12 1991-07-12 Pharmaceutical agents

Country Status (2)

Country Link
GB (1) GB9115107D0 (en)
UA (1) UA27711C2 (en)

Also Published As

Publication number Publication date
UA27711C2 (en) 2000-10-16

Similar Documents

Publication Publication Date Title
GB9126354D0 (en) Pharmaceutical agents
GB9121204D0 (en) Medicament
GB2269382B (en) Pharmaceutical compounds
HU9300804D0 (en) Pharmaceutical preparatives
GB9121463D0 (en) Medicament
GB9102727D0 (en) Pharmaceutical agent
IL101625A0 (en) Pharmaceutical compound
IL101624A0 (en) Pharmaceutical compound
GB9000241D0 (en) Pharmaceutical use
GB9115107D0 (en) Pharmaceutical agents
GB9113622D0 (en) Medicinal agents
GB9104124D0 (en) Pharmaceutical agent
GB9104123D0 (en) Pharmaceutical agent
ZA919771B (en) Pharmaceutical agents
GB9208106D0 (en) Pharmaceutical agents
GB9104307D0 (en) New pharmaceutical use
GB9104306D0 (en) New pharmaceutical use
GB9104269D0 (en) New pharmaceutical use
GB9123204D0 (en) New pharmaceutical use
GB9113850D0 (en) New pharmaceutical use
GB9113918D0 (en) New pharmaceutical use
GB9123202D0 (en) New pharmaceutical use
GB9113943D0 (en) New pharmaceutical use
GB9123203D0 (en) New pharmaceutical use
GB9113163D0 (en) Medicinal